Technology areas: Communications • Medical Devices & Mechanical Engineering
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Laxmi Therapeutic Devices Inc. manages a company patent portfolio with 4 pending office actions. These 4 pending office actions are situated within the Medical Devices & Mechanical Engineering technology area. The prosecution involves distinct examiners for the cases. This distribution across distinct examiners indicates that the company interacts with different individuals at the patent office.
The work is organized into 2 distinct art units. These 2 distinct art units fall under the Medical Devices & Mechanical Engineering umbrella. CERIONI, DANIEL LEE is the busiest examiner for the company. This examiner is responsible for 1 pending office action. The 1 pending office action under CERIONI, DANIEL LEE represents the current concentration of work for this examiner.
The distinct examiners and the 2 distinct art units provide the technical review for the portfolio. Practitioners should monitor the 4 pending office actions for consistent results across the different examiners. The Medical Devices & Mechanical Engineering technology area remains the primary focus for these filings. CERIONI, DANIEL LEE and the other examiners handle the ongoing prosecution.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CERIONI, DANIEL LEE | 1 | 64.3% | +28.0% |
| MESSERSMITH, ERIC J | 1 | 69.4% | +25.0% |
| PADDA, ARI SINGH KANE | 1 | 23.1% | +14.5% |
| AFRIFA-KYEI, ANTHONY D | 1 | 65.4% | +13.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19205598 | DERMAL SENSOR FOR DETERMINING ANALYTE CONCENTRATIONS | PADDA, ARI SINGH KANE | 28d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19205598 | DERMAL SENSOR FOR DETERMINING ANALYTE CONCENTRATIONS | PADDA, ARI SINGH KANE | 28d overdue |
| 19258209 | SMALL-SCALE ANALYTE SENSORS | MESSERSMITH, ERIC J | 8d overdue |
| 19288372 | DETECTION OF SIGNAL VARIATIONS DUE TO PRESSURE ON ANALYTE SENSOR | CERIONI, DANIEL LEE | 22d |
| 18536176 | SYSTEM AND METHOD FOR WIRELESS TRANSMISSION OF GLUCOSE DATA | AFRIFA-KYEI, ANTHONY D | — |
| Art Unit | Apps |
|---|---|
| 3791 | 3 |
| 2686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19288372 | DETECTION OF SIGNAL VARIATIONS DUE TO PRESSURE ON ANALYTE SENSOR | CERIONI, DANIEL LEE | 3791 | §103 | Final Rejection | 22d | Pending | Aug 01, 2025 |
| 19258209 | SMALL-SCALE ANALYTE SENSORS | MESSERSMITH, ERIC J | 3791 | §112 | Non-Final OA | 8d overdue | Pending | Jul 02, 2025 |
| 19205598 | DERMAL SENSOR FOR DETERMINING ANALYTE CONCENTRATIONS | PADDA, ARI SINGH KANE | 3791 | §103§112 | Final Rejection | 28d overdue | Pending | May 12, 2025 |
| 18536176 | SYSTEM AND METHOD FOR WIRELESS TRANSMISSION OF GLUCOSE DATA | AFRIFA-KYEI, ANTHONY D | 2686 | §103 | Non-Final OA | — | Pending | Dec 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLaxmi Therapeutic Devices Inc. has 4 pending office actions as of October 2026, spread across 2 art units and 4 examiners.
Daniel Lee Cerioni has the most, with 1 of Laxmi Therapeutic Devices Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
